Status:

RECRUITING

Behavioral Insomnia Treatment in Mild Traumatic Brain Injury

Lead Sponsor:

The University of Texas Health Science Center at San Antonio

Collaborating Sponsors:

Congressionally Directed Medical Research Programs

Hope Health Research Institute

Conditions:

Insomnia

Mild Traumatic Brain Injury

Eligibility:

All Genders

18-45 years

Phase:

NA

Brief Summary

This is a single site, two-armed random controlled trials (RCT) comparing six sessions of Cognitive Behavioral Therapy for Insomnia (CBT-I) with four sessions of Brief Behavioral Therapy for Insomnia ...

Detailed Description

The purpose of this study is to identify the optimal behavioral treatment for insomnia in service members with comorbid insomnia and prolonged postconcussive symptoms following Mild Traumatic Brain In...

Eligibility Criteria

Inclusion

  • Active duty U.S. military service members.
  • At least 18 years of age.
  • Ability to provide informed consent and follow study-related instructions.
  • Self-report of a Mild Traumatic Brain Injury (mTBI) at least 3 months prior to enrollment based on self-report.
  • At least 2 postconcussive symptoms scored \> 2 (moderate) on the Neurobehavioral Symptom Inventory (NSI), with at least 1 of these symptoms from the cognitive domain in addition to the sleep disturbances item.
  • Clinically significant chronic insomnia disorder assessed by an independent evaluator using the Structured Clinical Interview for Sleep Disorders-Revised (SCISD-R)\_No Split Week Self-Assessment of Sleep Survey (SASS-Y).
  • Minimum score of 15 on the Insomnia Severity Index (ISI).
  • Plans to be in the area for the next 3 months.
  • Stable on psychotropic and hypnotic medications for at least 1 month.
  • Stable on continuous positive airway pressure therapy if diagnosed with sleep apnea for at least 1 month.

Exclusion

  • Moderate TBI (e.g., skull fracture, brain hemorrhage, hematoma) indicated by self-report or medical record.
  • Any sleep, medical, or psychiatric disorder requiring urgent treatment (e.g., suicide risk, substance use, insomnia with occupational impairment in high risk professions; very short sleep duration of less than 4 hours on average; bipolar disorder or psychosis) or that otherwise interferes with the completion of the baseline assessment.
  • Working night shifts (i.e., duty later than 9:00 pm or before 5:30 am) more than 3 times per month.
  • Planned major surgery.
  • Pregnancy, assessed by self-report and review of medical record.

Key Trial Info

Start Date :

December 3 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2027

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT06551987

Start Date

December 3 2024

End Date

September 1 2027

Last Update

January 7 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Carl R. Darnall Army Medical Center

Fort Cavazos, Texas, United States, 76544